Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Waldencast plc operates as a specialized skincare enterprise, delivering sophisticated treatments aimed at improving various dermatological conditions. Its product offerings are crafted to minimize the visual impact of early aging, skin damage, uneven pigmentation, acne, and harm from sun exposure. These solutions are predominantly distributed through professional avenues such as dermatologists, plastic surgeons, medical spas, and other skincare professionals. The company's portfolio encompasses Obagi Medical, which provides groundbreaking skincare products designed to alleviate signs of skin aging, treat issues like dark spots, hyperpigmentation, and fine lines, while simultaneously protecting and enhancing skin's overall tone and texture. Additionally, its Obagi Clinical line features products specifically developed to stave off the initial indicators of skin aging. Founded in 1988, Waldencast plc is based in White Plains, New York.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Target Price
The average target price of WALD is 2.4 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas